Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)— 510(k) K262792

Name: FDA 510(k) clearance K262792
Creator: U.S. Food and Drug Administration
Published: 2026-08-12

Substantially Equivalent

Hologic, Inc.

FDA 510(k) clearance K262792 for Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09), Substantially Equivalent on 2026-08-12. Applicant: Hologic, Inc.. Device class: 2.

Clearance details

Applicant: Hologic, Inc.
Product code: Code KNW
Device class: Class 2
Regulation: 21 CFR 876.1075
Advisory panel: Gastroenterology, Urology
Date received: 2026-08-06
Decision date: 2026-08-12
Decision: Substantially Equivalent
Clearance type: Special
Location: Malborough, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KNW

view all

K260517 — Automatic Core Biopsy Instrument2026-08-28
K262571 — EnCor EnCompass Breast Biopsy and Tissue Removal System2026-08-14
K260572 — Marrow Marxman2026-08-04
K261196 — Promisemed VeriEcto Automatic Biopsy Needles2026-05-12
K260365 — Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System Control Module +5 more2026-03-04

More clearances from Hologic, Inc.

view all

K253634 — CoolSeal Generator® (CSL-200-90)2026-06-17
K251993 — Panther Fusion GI Expanded Bacterial Assay2025-09-25
K243341 — Genius AI Detection 2.02025-07-31
K243396 — Aptima SARS-CoV-2 Assay2025-02-13
K243935 — Aptima CMV Quant Assay2025-01-17

Adverse events under product code KNW

product code KNW

Death: 9
Injury: 965
Malfunction: 10,444
Other: 3
Total: 11,421

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.